Synthesis of a 11C-labelled taxane derivative by [1- 11C]acetylation

9Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The 11C-labelling of the taxane derivative BAY 59-8862 (1), a potent anticancer drug, was carried out as a module-assisted automated multi-step synthesis procedure. The radiotracer [11C]1 was synthesized by reacting [1-11C]acetyl chloride (6) with the lithium salt of the secondary hydroxy group of precursor 3 followed by deprotection. After HPLC purification of the final product [11C]1, its solid-phase extraction, formulation and sterile filtration, the decay-corrected radiochemical yield of [11C]1 was in the range between 12 and 23% (related to [11C]CO2; n = 10). The total synthesis time was about 54 min after EOB. The radiochemical purity of [11C]1 was greater than 96% and the chemical purity exceeded 80%. The specific radioactivity was 16.8 ± 4.7 GBq/μmol (n = 10) at EOS starting from 80 GBq of [11C]CO2. Copyright © 2006 John Wiley & Sons, Ltd.

Cite

CITATION STYLE

APA

Mäding, P., Zessin, J., Pleiß, U., Füchtner, F., & Wüst, F. (2006). Synthesis of a 11C-labelled taxane derivative by [1- 11C]acetylation. Journal of Labelled Compounds and Radiopharmaceuticals, 49(4), 357–365. https://doi.org/10.1002/jlcr.1059

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free